Combining enhanced imaging capabilities, workflow efficiencies and artificial intelligence (AI)-enabled technology to improve the diagnosis and management of health conditions in women, Samsung has launched the V6 ultrasound system.
Advances in artificial intelligence (AI) technology and image sharing tools with Samsung’s new V6 ultrasound platform may facilitate enhanced workflow efficiencies in the management of women’s health conditions.
Samsung noted that key advances with the V6 ultrasound system include:
• one-click fetal growth measurements with the semi-automated BiometryAssist™ feature;
• AI-enabled uterus measurements to help detect uterine-related abnormalities with UterineAssist™; and
• real-time image sharing between sonographers and referring physicians with the SonoSync™ feature.
The V6 ultrasound platform also features a miniER7 endocavity transducer, which gives clinicians a 180-degree field of view, a frequency range between 2 and 12 MHz, and design enhancements that may enhance patient comfort, according to Samsung.
“The V6 was developed with the clinical needs of women’s health and urology specifically in mind,” said Tracy Bury, a women’s health segment leader for Boston Imaging, the United States headquarters of Samsung’s digital radiography and ultrasound business. “We’re proud to offer a new product that is not only accessible to a broad group of clinicians but also has innovative, automated features that can make patient care simpler and more efficient.”
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography News: FDA Grants Expanded 510(k) Clearance for AI-Powered SmartMammo Dx DBT Software
November 29th 2024Originally cleared by the FDA in 2021, the SmartMammo Dx software for digital breast tomosynthesis (DBT) can now be utilized with the Senographe Pristina mammography systems from GE HealthCare.